June 8, 2021

Neutralization against B.1.351 and B.1.617.2 with Sera of COVID-19 Recovered Cases and Vaccinees of BBV152

Category: Article Summary

Topic: Vaccines and Immunity

Keywords (Tags): vaccination, variants

• [Pre-print, not peer-reviewed] Sera from individuals fully vaccinated with the inactivated virus SARS-CoV-2 vaccine Covaxin (n=17) showed a 3-fold reduction in neutralizing activity against the B.1.351 (Beta) and B.1.617.2 (Delta) variants of concern compared with the parent D614G variant. Similarly, sera from individuals recovered from COVID-19 showed a 3-fold and 5-fold reduction in neutralizing activity against the B.1.351 (Beta) and B.1.617.2 (Delta) variants, respectively.

Yadav et al. (June 7, 2021). Neutralization against B.1.351 and B.1.617.2 with Sera of COVID-19 Recovered Cases and Vaccinees of BBV152. Pre-print downloaded Jun 8 from https://doi.org/10.1101/2021.06.05.447177